Ignite Creation Date:
2024-05-06 @ 12:41 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03822468
Status:
COMPLETED
Last Update Posted:
2024-06-27
First Post:
2019-01-28
Brief Title:
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR HER2- Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-28
First Submit QC Date:
January 28 2019
Study First Post Date:
2019-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-04-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-05-09
Disp First Submit QC Date:
April 3 2024
Disp First Post Date:
2024-04-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-10-03
Last Update Post Date:
2024-06-27
Last Update Post Date Type:
ACTUAL